Line 1: | Line 1: | ||
− | + | <html lang="en"> | |
− | iGEM Technion 2017 | + | <head> |
− | + | <!-- Title for the page & metadata --> | |
+ | <title>Tolegen, by iGEM Technion 2017</title> | ||
+ | <meta charset="utf-8"> | ||
+ | <meta name="navbar" content="width=device-width, initial-scale=1"> | ||
+ | <!-- Bootstrap CSS --> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2017.igem.org/Team:TECHNION-ISRAEL/bootstrap.min.css/CSS?action=raw&ctype=text/css"/> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2017.igem.org/Team:TECHNION-ISRAEL/bootstrap-theme.min.css/CSS?action=raw&ctype=text/css"/> | ||
+ | <!-- Bootstrap JS --> | ||
+ | <script type="text/javascript" src="https://2017.igem.org/Team:TECHNION-ISRAEL/jquery-2.1.1.min.js/Javascript?action=raw&ctype=text/javascript"></script> | ||
+ | <script type="text/javascript" src="https://2017.igem.org/Team:TECHNION-ISRAEL/bootstrap.min.js/Javascript?action=raw&ctype=text/javascript"></script> | ||
+ | <!-- ===================Basic Bootstrap's CSS and JS=================== --> | ||
+ | <!-- Our wiki CSS --> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2017.igem.org/Team:TECHNION-ISRAEL/CSS?action=raw&ctype=text/css"/> | ||
+ | |||
+ | <!-- fonts --> | ||
+ | <!-- Fonts --> | ||
+ | <script src="https://use.fontawesome.com/597ba5ca72.js"></script> | ||
+ | <link href="https://fonts.googleapis.com/css?family=Assistant" rel="stylesheet" rel="stylesheet"> | ||
+ | <link href="https://fonts.googleapis.com/css?family=Quicksand:400,500" rel="stylesheet"> | ||
+ | <style> | ||
+ | |||
+ | body{ | ||
+ | |||
+ | margin-left: 0; | ||
+ | margin-right: 0; | ||
+ | margin-top: 0; | ||
+ | padding-top: 0; | ||
+ | } | ||
+ | |||
+ | .mw-content-ltr ul, .mw-content-rtl .mw-content-ltr ul {padding-top: 10px;} | ||
+ | .imglog { | ||
+ | display: inline; | ||
+ | padding: 0 20px 0 20px; | ||
+ | width: 160px; | ||
+ | } | ||
+ | |||
+ | .navbar-inverse { | ||
+ | |||
+ | padding-top: 20px; | ||
+ | background-image: none; | ||
+ | background-color: transparent ; | ||
+ | border: none; | ||
+ | } | ||
+ | |||
+ | .dropdown-toggle { | ||
+ | margin-top : -1000px; ; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | |||
+ | <!------ snippet hover navbar-----> | ||
+ | |||
+ | <style type="text/css"> | ||
+ | @media screen and (min-width: 768px){ | ||
+ | .dropdown:hover .dropdown-menu, .btn-group:hover .dropdown-menu{ | ||
+ | display: block; | ||
+ | } | ||
+ | .dropdown-menu{ | ||
+ | margin-top: 0; | ||
+ | } | ||
+ | .dropdown-toggle{ | ||
+ | margin-bottom: 2px; | ||
+ | } | ||
+ | .navbar .dropdown-toggle, .nav-tabs .dropdown-toggle{ | ||
+ | margin-bottom: 0; | ||
+ | } | ||
+ | } | ||
+ | </style> | ||
+ | <script type="text/javascript"> | ||
+ | $(document).ready(function(){ | ||
+ | $(".dropdown, .btn-group").hover(function(){ | ||
+ | var dropdownMenu = $(this).children(".dropdown-menu"); | ||
+ | if(dropdownMenu.is(":visible")){ | ||
+ | dropdownMenu.parent().toggleClass("open"); | ||
+ | } | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
− | + | </head> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | <body> | |
− | + | <div class="row" style= "margin-top: -12px"> | |
− | + | <img src="https://static.igem.org/mediawiki/2017/1/17/T--TECHNION-ISRAEL--home-new.gif" class=" img-center cont_cover" width="100%" style="margin-top: 0px;"> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | / | + | |
− | + | ||
− | + | ||
− | / | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | </div> | |
+ | |||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
+ | <div class= "image-center " style= "margin:auto; width:1063px ;"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/9/93/T--TECHNION-ISRAEL--redmicro.png" alt= "project" class="imglog" style= "margin-left:0px"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/6/61/T--TECHNION-ISRAEL--redlab%281%29.png" alt= "wetlab" class="imglog"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/a/a8/T--TECHNION-ISRAEL--redparts.png" alt= "parts" class="imglog"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/0/00/T--TECHNION-ISRAEL--hp%281%29.png" alt= "human practices" class="imglog" style= "margin-left:25px"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/3/30/T--TECHNION-ISRAEL--judg%281%29.png" alt= "judging" class="imglog" style= "margin-left:20px"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/a/a3/T--TECHNION-ISRAEL--team%281%29.png" alt= "team" class="imglog"> | ||
+ | </div> | ||
− | + | <nav class= "navbar navbar-inverse " style= "margin:auto; width:1063px ;"> | |
− | + | <div class="dropdown"> | |
− | + | <button class="dropdown-toggle" type="button" data-toggle="dropdown">project | |
− | + | <span class="caret"></span></button> | |
− | + | <ul class= "dropdown-menu" style="margin: 0px; left: 2px;"> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Description"> description </a> </li> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/cell_lines"> cell lines </a> </li> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Design"> design </a> </li> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/delay_mechanism"> delay mechanism </a> </li> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/kill_switch"> kill switch </a> </li> | |
− | + | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/assay" > assay </a> </li> | |
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | <div class="dropdown"> | ||
+ | <button class="dropdown-toggle" type="button" data-toggle="dropdown">wet lab | ||
+ | <span class="caret"></span></button> | ||
+ | <ul class= "dropdown-menu" style="margin: 0px; left: 2px;" > | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Results"> results </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Notebook"> notebook </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Experiments"> protocols </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/InterLab"> interlab </a> </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | <div class="dropdown"> | ||
+ | <button class="dropdown-toggle" type="button" data-toggle="dropdown">parts | ||
+ | <span class="caret"></span></button> | ||
+ | <ul class= "dropdown-menu" style="margin: 0px; left: 2px;"> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Parts"> parts </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Basic_Part"> basic part </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Composite_Part"> composite part </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Part_Collection"> part collection </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:Example2/Improve"> improvement </a> </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | <div class="dropdown"> | ||
+ | <button class="dropdown-toggle" type="button" data-toggle="dropdown" style= "width: auto"; >human practices | ||
+ | <span class="caret"></span></button> | ||
+ | <ul class= "dropdown-menu" style="margin: 0px; left: 18px; width: 170px;" > | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Silver"> human practices </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Engagement" > Education & Public Engagement </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/HP/Gold_Integrated"> integrated HP </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/ethics"> ethics </a> </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | <div class="dropdown"> | ||
+ | <button class="dropdown-toggle" type="button" data-toggle="dropdown">judging | ||
+ | <span class="caret"></span></button> | ||
+ | <ul class= "dropdown-menu" style="margin: 0px; left: 2px "> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Safety"> safety </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Collaborations"> collaboration </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/acheivments"> acheivments </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Model"> modelling </a> </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | <div class="dropdown"> | ||
+ | <button class="dropdown-toggle" type="button" data-toggle="dropdown">team | ||
+ | <span class="caret"></span></button> | ||
+ | <ul class= "dropdown-menu" style="margin: 0px; left: 2px;"> | ||
+ | <li> <a href =" https://2017.igem.org/Team:TECHNION-ISRAEL/Team"> members </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/Attributions"> attributions </a> </li> | ||
+ | <li> <a href ="https://2017.igem.org/Team:TECHNION-ISRAEL/gallery"> gallery </a> </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </nav> | ||
+ | <br> | ||
+ | <br> | ||
− | + | <div class = "container-fluid"> | |
− | + | <br> | |
− | + | <br> | |
− | + | <p style="text-align:center; font-size:26px; font-family:'Quicksand', sans-serif;"> | |
− | + | A preventative treatment for autoimmune disease and allergies | |
− | + | </p> | |
− | + | <br> | |
− | + | <div class="row"> | |
− | + | <div class = "col-md-offset-2 col-md-8" > | |
− | + | <div class= "row"> | |
− | + | <div class = "col-md-12" > | |
− | + | ||
− | + | <br> | |
− | + | ||
− | + | <p> Autoimmune disease and allergies are an increasingly common phenomenon in the Western world. An estimated 73 million people suffer from allergies and autoimmune disease in the United States alone. To date, many of these diseases lack treatment and pose an incredible financial burden on both the patients and society. | |
− | + | <br> | |
− | + | <br> | |
− | + | We set out to create a preventative treatment for allergies and autoimmune disease by utilizing the innate mechanism of Central Tolerance. We’ve designed a modular plasmid based platform that will allow for inducible expression, and display, of target antigens on the membrane of Hematopoietic Stem Cells (HSCs). In our project, murine Hematopoietic Progenitor Cells (HPC-7) were used as a model for HSCs and transfected with our plasmid. Additionally, we attempted to show apoptosis in an immature B cell model (WEHI-231) as a result of our treatment, closely approximating the process of Central Tolerance. In the future this technology may be used to engineer HSCs harvested from cord blood and allow for a cost effective preventative treatment. | |
− | + | </p> | |
− | + | </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | . | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | . | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | / | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | </body> | |
− | + | </html> | |
− | + | {{:Team:TECHNION-ISRAEL/sponsors}} | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | } | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + |
Revision as of 15:59, 30 October 2017
A preventative treatment for autoimmune disease and allergies
Autoimmune disease and allergies are an increasingly common phenomenon in the Western world. An estimated 73 million people suffer from allergies and autoimmune disease in the United States alone. To date, many of these diseases lack treatment and pose an incredible financial burden on both the patients and society.
We set out to create a preventative treatment for allergies and autoimmune disease by utilizing the innate mechanism of Central Tolerance. We’ve designed a modular plasmid based platform that will allow for inducible expression, and display, of target antigens on the membrane of Hematopoietic Stem Cells (HSCs). In our project, murine Hematopoietic Progenitor Cells (HPC-7) were used as a model for HSCs and transfected with our plasmid. Additionally, we attempted to show apoptosis in an immature B cell model (WEHI-231) as a result of our treatment, closely approximating the process of Central Tolerance. In the future this technology may be used to engineer HSCs harvested from cord blood and allow for a cost effective preventative treatment.